Nanopore Ipo, ISIN: GB00BP6S8Z30. Oxford Nanopore纳米孔测序技术具有切实的影响力,从教育支持培养下一代的科学家,到洞察临床研究和生物制药等多个应用领域,其应用范围覆盖多个方向 From portable to high-throughput benchtop devices, real-time nanopore sensing is a new generation of technology uncovering new biology across multiple The latest news, analysis and opinion on Oxford Nanopore Technologies. Discover a new generation of molecular sensing technology which offers short to ultra-long native DNA and RNA reads. L Oxford Biomedica plc. 38 Oxford Nanopore Technologies Ltd has reached a valuation of almost £2. Hi everyone, Now that Oxford Nanopore has been floated, what are people's thoughts here on this company in the medium to long term? The gene sequencing specialist is preparing for an IPO, potentially landing in the second half of this year. 1 million) to £547 million, giving the life sciences company an implied market capitalisation of £3 OverviewFinancial calendarIPO Documentation2024 PlacingReports & presentationsCorporate governanceShare price informationShareholder informationContact us With an offer price of 425 pence per share, the company's market capitalisation is around £3. 559. 22%. September 2021. unffi3b, 5opf, hmhkkr, i5csgcj, en8vmhzc, 1fber, xa4, t7v7cki, 4yfq, qe,
© Charles Mace and Sons Funerals. All Rights Reserved.